The Innovator U.S. Equity Ultra Buffer ETF – February (UFEB) is an exchange-traded fund, or ETF — a pooled investment that trades on an exchange like a stock. UFEB belongs to a distinctive category of funds known as "defined outcome" or "buffer" ETFs, which aim to provide investors with a specific, pre-set range of potential returns over a fixed time window rather than simply mirroring the stock market.
Issued by Innovator Capital Management, UFEB gives investors exposure to the price performance of large-cap U.S. stocks — represented by the SPDR S&P 500 ETF Trust (SPY) — but with two important modifications: a cap on upside gains and a buffer against a portion of downside losses. This combination has made the fund popular among investors seeking equity participation with reduced, more predictable downside risk. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry.
UFEB's investment objective is to deliver returns that match the price return of the SPDR S&P 500 ETF Trust, up to a predetermined upside cap, while providing a buffer against losses of between 5% and 35% over a defined one-year period. This period — called the "outcome period" — runs from February 1 through January 31 of the following year, at which point the fund's cap and buffer are reset and a new cycle begins.
The fund is actively managed and implements its strategy primarily through FLEX Options — customizable, exchange-listed options contracts — that reference the SPDR S&P 500 ETF Trust. Rather than holding the underlying stocks directly, UFEB holds a small number of option positions (typically just a handful of holdings) designed to produce its defined outcome. Under normal circumstances, at least 80% of the fund's net assets are invested in instruments providing exposure to the underlying ETF.
Because the strategy is built around options, UFEB's portfolio holdings look very different from a conventional index ETF. Its sector exposure, however, broadly mirrors the S&P 500's composition, with the information technology sector typically representing the largest weighting, followed by financials, health care, and consumer discretionary names. From what I see, this options-based approach keeps the fund focused yet distinct.
UFEB is non-diversified, meaning it may concentrate its investments more heavily than diversified funds. It trades on the Cboe BZX Exchange, and its net expense ratio is 0.79%. The fund is not intended to generate dividend income, as it does not receive or benefit from dividend payments on its option positions.
The specific cap and buffer values are reset each year. For example, at the start of the February 2026–January 2027 outcome period, the fund's upside cap was set at 11.39% before fees (10.60% after accounting for the 0.79% management fee), while the buffer covered losses between 5% and 35%. Investors bear the first 5% of losses, as well as any losses beyond 35%, on a one-to-one basis.
UFEB attracts attention primarily because of its defined downside protection. In a conventional S&P 500 index fund, investors absorb the full extent of any market decline. UFEB, by contrast, seeks to shield investors from a meaningful slice of those losses — the portion between 5% and 35% — over each outcome period. This makes the fund a potential tool for risk-averse investors who want to remain invested in U.S. large-cap equities while reducing the anxiety of severe drawdowns.
The fund also offers a clearly defined risk/reward framework that appeals to financial advisors and individual investors engaged in planning. Because the cap and buffer are announced at the start of each outcome period, investors know in advance the maximum gain and the extent of the protection they can expect if they hold the fund for the full period.
From a portfolio-construction standpoint, UFEB can serve as a complement to core equity holdings, offering sector exposure to the broad U.S. market with a built-in cushion against intermediate-sized declines. Its defined-outcome design is particularly relevant during periods of elevated market uncertainty, when the value of downside protection tends to be most visible. One thing that stands out is how this structure provides a more predictable profile than standard index funds.
UFEB's structured design carries several important trade-offs that investors should understand. First, the upside cap means investors forfeit gains above the predetermined level — in strong bull markets, the fund is likely to underperform a plain S&P 500 index fund. Over multiple outcome periods, capped gains can make it difficult to fully recover from prior losses.
Second, the buffer has defined limits. Investors bear the first 5% of losses in each outcome period, as well as all losses beyond 35%. The outcomes are also only fully realized by investors who hold shares for the entire outcome period; those who buy or sell mid-period may experience very different returns.
Additional considerations include counterparty risk, since the fund depends on the Options Clearing Corporation and its clearing members to honor FLEX Options obligations; tracking differences, because the option-based structure may not move in lockstep with the underlying ETF on a day-to-day basis; and the absence of dividend income, making the fund unsuitable for income-seeking investors. The 0.79% expense ratio also reduces net returns.
In my research process, I often turn to Tickeron’s AI Screener to quickly compare defined outcome ETFs like UFEB against peers using technical indicators, fundamentals, and volatility filters. It helps surface ideas that align with specific risk parameters without sifting through thousands of options manually. This tool has become a regular part of how I evaluate structured products and their fit within broader portfolios.
The Innovator U.S. Equity Ultra Buffer ETF – February offers a distinctive approach to U.S. large-cap investing: participation in equity market gains up to a fixed cap, paired with a buffer against a defined band of losses. Its annual reset structure, transparently disclosed cap and buffer, and focus on downside protection distinguish it from traditional index funds. For investors who value a more predictable risk/reward profile over uncapped upside, UFEB remains a noteworthy tool within the growing defined-outcome ETF category. I’m watching this closely as market conditions evolve.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.
The 10-day moving average for UFEB crossed bearishly below the 50-day moving average on November 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UFEB as a result. In 32 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 41%.
The Moving Average Convergence Divergence Histogram (MACD) for UFEB turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 18 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 35%.
UFEB moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UFEB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where UFEB advanced for three days, in 232 of 378 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
UFEB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 298 of 483 cases where UFEB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.